Popular Articles

Parkinson's Disease: Novel Drug Discovery Tool Could Identify Promising New Therapies
Researchers funded by the National Institutes of Health have turned simple baker"s yeast into a virtual army of medicinal chemists capable of rapidly searching for drugs to treat Parkinson"s disease.
generic viagra online
Aetna Pilot Helps Physicians Improve Care For Diabetics
Aetna (NYSE: AET) and Total Therapeutic Management (TTM) announced the results of a pilot program in Southeastern Pennsylvania and South Florida that improved patient care and increased the number of physicians recognized by the National Committee for Quality Assurance (NCQA) Diabetes Physician Recognition Program. Funded by Amylin Pharmaceuticals, Inc., the program included outreach to physicians, chart reviews, and face-to-face meetings to discuss appropriate screening tests and gauge how patient care was being managed. Of the 40 physicians who participated in the 2008 pilot, 17 were recognized by the NCQA for providing high-quality care to patients with diabetes. Findings from the program were presented at the ISPOR international meeting held in Orlando, Florida.
News of the day
Hospitals, White House Reach Accord On Cuts To Pay For Reform
Major hospital groups reached an agreement Monday with the White House and Senate Democrats to accept $155 billion in payment cuts over ten years, a concession that would help pay for proposed health care reforms, the Washington Post reports. Government savings would come mainly from lower Medicare and Medicaid payments to the hospitals, and smaller subsidies for providing care to the uninsured. Hospitals expect to make up some of the losses by increasing their volume as anticipated reforms bring health insurance to many of the 47 million Americans who don"t have coverage.
Sexual Health

In A Rare Disorder, A Familiar Protein Disrupts Gene Function

As reported this week in the open-access journal PLoS Biology, an international team of scientists studying a rare genetic disease has discovered that a bundle of proteins already known to be important for keeping chromosomes together also plays an important role in regulating gene expression in humans. In addition to shedding light on the biological roles of these proteins, the research may lead to the development of better diagnostic tools for Cornelia de Lange syndrome (CdLS), a multisystem developmental disease. Ian D. Krantz, of The Children"s Hospital of Philadelphia, and colleagues investigated cohesin, a protein complex consisting of at least four proteins that form a ring that encircles chromosomes during cell division. Cohesin"s long-established "canonical" role is to control chromatids-the long strands that chromosomes form during DNA replication. However, one open question in biology has been, "What does cohesin do when cells are not dividing?" The paper from Krantz"s team provides part of the answer, as the first study in human cells to identify genes that are dysregulated when cohesin doesn"t work properly. Cohesin"s role in dysregulating gene expression has attracted considerable scientific interest with a recent discovery that it may also be implicated in cancer. Using DNA microarrays, Krantz and colleagues did a genome-wide analysis of mutant cell lines from 16 patients with severe CdLS. All the cells had mutations in the NIPBL gene, which plays a role in moving cohesin onto and off chromosomes, or in genes encoding components of the cohesin complex itself. The study team identified hundreds of genes that were dysregulated in patient samples compared to samples from healthy individuals, and also detected specific gene expression profiles that are unique to CdLS patients. Importantly, said Krantz, the expression levels of dysregulated genes corresponded to the severity of the disease. "We found that gene expression is exquisitely regulated by cohesin and the NIBPL gene," said Krantz. "The gene expression patterns we found have great potential to be used in a diagnostic tool for Cornelia de Lange syndrome." He added that gene profiling arrays have the potential to be developed as single-platform tools to diagnose, from a patient"s blood sample, not only CdLS, but also a variety of other developmental disorders. Funding: JL is supported by a CdLS Foundation Fellowship Grant; IDK is supported by PO1 HD052860, NICHD; KS was supported in part by a grant of the Genome Network Project and Grant-in-Aid for Scientific Research (S) from the MEXT, Japan. MAD. is supported by KO8 HD055488, NICHD. This project is funded, in part, under a grant with the Pennsylvania Department of Health (to NBS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing interests statement: The authors declare that no competing interests exist. Citation: "Transcriptional Dysregulation in NIPBL and Cohesin Mutant Human Cells." Liu J, Zhang Z, Bando M, Itoh T, Deardorff MA, et al. (2009) PLoS Biol 7(5):e1000119. doi:10.1371/journal.pbio.1000119 Plos Biology


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):